Ami Organics Ltd

Acutaas Chemicals Ltd has made the recording of its earnings call held on July 24, 2026, available on its official website. This follows SEBI regulations and an earlier intimation regarding the call. Investors can access the recording via a provided link on the company's website, www.acutaas.com, allowing them to review the discussions and financial updates presented during the call.

Acutaas Chemicals Limited announced its financial results for the first quarter ended June 30, 2026. The company reported a significant year-on-year increase in key financial metrics. Revenue from operations grew by 59.1% to ₹3,297 million, while Profit After Tax (PAT) surged by 70.4% to ₹750 million. EBITDA also saw a substantial rise of 122.1% to ₹1,131 million. The company highlighted improvements in gross and EBITDA margins. Acutaas Chemicals also mentioned receiving 'Great Place to Work' and 'Responsible Care' certifications. The management expressed confidence in achieving 25% revenue growth for the full year with stable margins.

Acutaas Chemicals Ltd announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The Board of Directors approved these results, which were recommended by the Audit Committee. A Limited Review Report was issued by the statutory auditors, M/s. Maheshwari & Co. The financial results will be published in newspapers and made available on the company's website. This filing complies with SEBI regulations.

Acutaas Chemicals Ltd announced that its Board of Directors, in a meeting held on July 24, 2026, considered and approved the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The results were reviewed and recommended by the Audit Committee and accompanied by a Limited Review Report from statutory auditors M/s Maheshwari & Co. The board meeting commenced at 11:00 a.m. and concluded at an unspecified time.

Acutaas Chemicals Ltd has announced that its Board of Directors will convene on July 24, 2026, to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The Audit Committee meeting will precede the Board meeting on the same day. Concurrently, the company has closed its trading window for designated persons from July 1, 2026, which will reopen 48 hours after the declaration of the financial results.

Acutaas Chemicals Ltd announced the promotion and designation of Mr. Anurag Shukla as 'General Manager Operations & Unit Head — Ankleshwar', effective July 2, 2026. This appointment designates him as a Senior Management Personnel (SMP) of the company. Mr. Shukla, who joined Acutaas Chemicals in September 2021, brings over 21 years of experience in pharmaceutical API and intermediates manufacturing, plant operations, and project management. His new role will involve overseeing the operations of the Ankleshwar facility. The Nomination and Remuneration Committee approved this change in accordance with SEBI Listing Regulations.

Acutaas Chemicals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, effective July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window is being closed to facilitate the consideration of the Unaudited Financial Results for the first quarter ending June 30, 2026. The window will reopen 48 hours after the declaration of these financial results. The date of the Board of Directors' meeting to approve these results will be communicated separately.

Acutaas Chemicals Ltd announced the conclusion of an inspection/search by the Central Goods & Service Tax & Central Excise (CGST & CE), Anti-evasion Department, Surat, Gujarat. The search, conducted under Section 67 of the CGST Act, 2017, at the company's registered office and manufacturing unit, concluded on June 23, 2026. The company stated that it has provided all necessary documents and clarifications. Importantly, no official document has been issued by the CGST department, and there is no material impact on the company's financials, operations, or other activities as a result of this inspection.

Acutaas Chemicals Ltd announced that the Central Goods & Service Tax & Central Excise (CGST & CE), Anti-evasion Department, Surat, Gujarat, initiated an inspection/search at the company's Sachin facility and registered office on June 22, 2026. The proceedings are ongoing, and the company is cooperating fully. Currently, there is no material impact on the company's financials or business operations. Acutaas Chemicals will provide further disclosures if any material updates arise.

Acutaas Chemicals Ltd announces that Acutaas Chemicals Electrolytes Private Limited (ACEPL) is no longer a wholly-owned subsidiary, effective May 19, 2026. This follows the allotment of 1,111 equity shares to A.R.Z Pharma Ltd, reducing Acutaas Chemicals' stake in ACEPL from 100% to 90%. The dilution does not affect management control, with ACEPL remaining under Acutaas Chemicals' management. The equity shares were issued at ₹52,490 per share, including a premium of ₹52,480.